Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)

NCT01338675 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Chronic Granulomatous Disease

Interventions

DRUG: Busulfan

Sponsor

Seoul National University Hospital